Dr Reddys Laboratories (RDY) Current Taxes (2009 - 2026)
Dr Reddys Laboratories (RDY) posted Current Taxes of $45.0 million for Q2 2026, down 4.56% on a QoQ basis from $47.1 million in Q1 2026, and down 63.4% year-over-year from $122.9 million in Q2 2025.
Analysis
Dr Reddys Laboratories (RDY) Current Taxes (2009 - 2026) Analysis & Trends
Dr Reddys Laboratories has reported Current Taxes for 18 years, with the latest figure at $45.0 million in Q2 2026.
- On a quarterly basis, Current Taxes fell 63.4% year-over-year to $45.0 million in Q2 2026; TTM through Jun 2026 was $45.0 million, a 63.4% decrease from a year earlier, with the FY2026 full-year figure at $46.0 million, up 31.43% from the prior year.
- Current Taxes was $45.0 million for Q2 2026 at Dr Reddys Laboratories, down from $47.1 million in the prior quarter.
- The five-year high for Current Taxes was $122.9 million in Q2 2025, with the low at $15.8 million in Q3 2022.
- Average Current Taxes over 5 years is $46.6 million, with a median of $46.1 million recorded in 2026.
- The sharpest annual moves came in 2023 and 2026: Current Taxes jumped 208.76% in 2023, then slumped 63.4% in 2026.
- Over 5 years, Current Taxes stood at $16.2 million in 2022, then surged by 208.76% to $50.1 million in 2023, then fell by 29.05% to $35.6 million in 2024, then jumped by 76.65% to $62.8 million in 2025, then declined by 28.38% to $45.0 million in 2026.
- The last three Current Taxes figures came in at $45.0 million (Q2 2026), $47.1 million (Q1 2026), and $62.8 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.33 Bn | 38.68 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.05 Bn | 18.16 Bn | 1.46 Bn | - |
| 3 | Dr Reddys Laboratories | 9.76 Bn | 9.58 Bn | 396.53 Mn | 45.00 Mn |
| 4 | Amneal Pharmaceuticals | 5.38 Bn | 5.25 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.27 Bn | 436.38 Mn | 2.10 Bn | - |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn | 2.00 Mn |
| 7 | Ani Pharmaceuticals | 1.51 Bn | 1.15 Bn | 165.89 Mn | 3.53 Mn |
| 8 | Amphastar Pharmaceuticals | 1.03 Bn | 737.26 Mn | 93.47 Mn | 546,000.00 |
| 9 | Fennec Pharmaceuticals | 393.12 Mn | 351.87 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 171.02 Mn | 171.02 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 45.00 Mn |
| Mar 31, 2026 | 47.15 Mn |
| Dec 31, 2025 | 62.83 Mn |
| Sep 30, 2025 | 87.45 Mn |
| Jun 30, 2025 | 122.93 Mn |
| Mar 31, 2025 | 34.97 Mn |
| Dec 31, 2024 | 35.57 Mn |
| Sep 30, 2024 | 60.76 Mn |
| Jun 30, 2024 | 58.24 Mn |
| Mar 31, 2024 | 28.20 Mn |
| Dec 31, 2023 | 50.13 Mn |
| Sep 30, 2023 | 48.21 Mn |
| Jun 30, 2023 | 53.94 Mn |
| Mar 31, 2023 | 26.08 Mn |
| Dec 31, 2022 | 16.24 Mn |
| Sep 30, 2022 | 15.77 Mn |
| Jun 30, 2022 | 23.12 Mn |
| Mar 31, 2022 | 21.48 Mn |
| Dec 31, 2021 | 21.19 Mn |
| Sep 30, 2021 | 17.69 Mn |